Prof. Dr. Limei Lin is currently the Director and Professor of the Pharmacy Skills Teaching Experiment Center of the School of Pharmacy, Hunan University of Traditional Chinese Medicine. She received her Ph.D. in Traditional Chinese Medicine from the China Academy of Chinese Medical Sciences in 2008. She worked as a Senior Engineer and Deputy Director of the R&D Institute at GPHL (2008–2010). She completed her Postdoctoral Fellow studies at the China Academy of Chinese Medical Sciences in 2010. In 2013, she moved to the Hunan University of Traditional Chinese Medicine and worked as an Associate Professor. In recent years, she has chaired and participated in the National Natural Science Foundation of China, the National Science and Technology Major Science and Technology Project "Major New Drug Creation", the National Traditional Chinese Medicine Public Welfare Industry Special Project, the National Development and Reform Commission Standardization Project, the Ministry of Education Doctoral Program Fund, the Hunan Provincial Outstanding Youth Fund and other projects. Her research topics mainly include active ingredients and quality standardization of traditional Chinese medicine, rapid detection and analysis technology for active/toxic components of traditional Chinese medicine and biological processing of toxic and harmful substances in traditional Chinese medicine to reduce toxicity and preserve/enhance efficiency.
Prof. Dr. Limei Lin is currently the Director and Professor of the Pharmacy Skills Teaching Experiment Center of the School of Pharmacy, Hunan University of Traditional Chinese Medicine. She received her Ph.D. in Traditional Chinese Medicine from the China Academy of Chinese Medical Sciences in 2008. She worked as a Senior Engineer and Deputy Director of the R&D Institute at GPHL (2008–2010). She completed her Postdoctoral Fellow studies at the China Academy of Chinese Medical Sciences in 2010. In 2013, she moved to the Hunan University of Traditional Chinese Medicine and worked as an Associate Professor. In recent years, she has chaired and participated in the National Natural Science Foundation of China, the National Science and Technology Major Science and Technology Project "Major New Drug Creation", the National Traditional Chinese Medicine Public Welfare Industry Special Project, the National Development and Reform Commission Standardization Project, the Ministry of Education Doctoral Program Fund, the Hunan Provincial Outstanding Youth Fund and other projects. Her research topics mainly include active ingredients and quality standardization of traditional Chinese medicine, rapid detection and analysis technology for active/toxic components of traditional Chinese medicine and biological processing of toxic and harmful substances in traditional Chinese medicine to reduce toxicity and preserve/enhance efficiency.